Clinical Trial Update: Mel vs BUCY+VP-16 Conditioning Regimen for MM Undergoing Auto-HSCT [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial comparing Mel vs BUCY+VP-16 conditioning for multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• BUCY+VP-16 conditioning
• Mel

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Autologous Hematopoietic Stem Cell Transplantation, Conditioning | Phase 2, Phase 3 | Status: UNKNOWN